NORTH AMERICAN SPECIALIZED COAGULATION LABORATORY

EIN: 411996160 501(c)(3) Medical Research

ROCHESTER, MN

Total Revenue
$329,023
Total Expenses
$291,533
Total Assets
$918,993
Net Assets
$918,127
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2000
Legal Domicile
MN
Principal Officer
ELIZABETH A PLUMHOFF MTASCP
Phone
5072811468
Tax Period
2024-01-01 to 2024-12-31

NORTH AMERICAN SPECIALIZED COAGULATION LABORATORY, founded in 2000, is a small nonprofit in the Medical Research sector that reported $329K in total revenue in fiscal year 2024. Revenue decreased 18% compared to the prior year. Expenses of $292K left a modest 11% surplus.

Mission

NASCOLA'S PRIMARY MISSION IS TO PROVIDE EXTERNAL QUALITY ASSESSMENT (PROFICIENCY TESTING) FOR TESTS USED TO DIAGNOSE BLEEDING OR PROTHROMBOTIC DISORDERS, THEREBY PROMOTING HIGH STANDARDS OF PERFORMANCE AND PRACTICE FOR SPECIALIZED COAGULATION LABORATORIES IN THE USA, CANADA, MEXICO, CENTRAL AMERICA AND THE CARIBBEAN. OTHER MISSIONS OF NASCOLA INCLUDE PROMOTING EDUCATION FOR PHYSICIANS, LABORATORY TECHNOLOGISTS, AND OTHER HEALTHCARE PROFESSIONALS, ENHANCING COMMUNICATION AMONG LABORATORIES PERFORMING SPECIALIZED COAGULATION TESTING, DEVELOPING GUIDELINES FOR APPROPRIATE USE, PERFORMANCE AND INTERPRETATION OF COAGULATION TESTS AND RESULTS, PROVIDING A FORUM FOR CRITICAL EVALUATION OF EXISTING AND NEW LABORATORY TEST PROCEDURES, INSTRUMENTATION AND REAGENTS, COLLABORATING WITH OTHER NATIONAL AND INTERNATIONAL ORGANIZATIONS FOCUSED ON PROVIDING EXTERNAL QUALITY ASSESSMENT FOR HEMOSTASIS AND THROMBOSIS TESTING, AND SUPPORTING COLLABORATIVE RESEARCH.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0
Program Service Revenue $322,048
Investment Income $6,975
Other Revenue $0
TOTAL REVENUE $329,023

Expense Breakdown

Grants Paid $0
Salaries & Benefits $51,886
Fundraising Expenses $0
Program Expenses $252,300
Other Expenses $239,647
TOTAL EXPENSES $291,533

Year-over-Year Comparison

2024 2023 Change
Revenue $329,023 $399,001 -0.2%
Expenses $291,533 $296,460 0.0%
Net Income $37,490 $102,541 -0.6%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
8
Independent Members
8
Employees
N/A
Volunteers
8

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
6
$51,886
Total Directors
8
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
ELIZABETH A PLUMHOFF MTASCP EXECUTIVE DI 10.00
Officer
$37,404 $0 $37,404
JANA GAUSMAN ASSOCIATE EX 10.00
Officer
$14,482 $0 $14,482
JING JIN MEMBER-AT-LA 5.00
Director
$0 $0 $0
ANDREW GOODWIN MD MEMBER-AT-LA 5.00
Director
$0 $0 $0
KRISTI SMOCK MD PRESIDENT 10.00
Officer Director
$0 $0 $0
MARIAN ROLLINS-RAVAL MD TREASURER 5.00
Officer Director
$0 $0 $0
RAE KERLIN BS MLS ASCP NCA MEMBER-AT-LA 5.00
Director
$0 $0 $0
NICOLE ZANTEK MD PHD VICE PRESIDE 5.00
Officer Director
$0 $0 $0
RICHARD MARLAR PHD PAST PRESIDE 5.00
Director
$0 $0 $0
SABRINA RACINE-BRZOSTEK MD PHD SECRETARY 5.00
Officer Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 $329,023 $291,533 $918,993 $37,490
2023 $399,001 $296,460 $880,637 $102,541
2022 $313,823 $285,688 $778,096 $28,135
2021 $470,660 $259,770 $749,961 $210,890
2020 $294,714 $236,571 $539,071 $58,143
2019 $310,787 $211,532 $480,928 $99,255
Explore More Nonprofits
Top 100 Nonprofits in Minnesota Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare NORTH AMERICAN SPECIALIZED COAGULATION LABORATORY with other nonprofits in Minnesota and across the country.